Investor FAQ
Smith & Nephew plc is quoted on the London Stock Exchange (symbol SN-L).
In the United States, the company's ordinary shares are traded in the form of American Depositary Shares, evidenced by ADRs, and trade on the New York Stock Exchange under the symbol SNN. Each American Depositary Share represents five ordinary shares.
Smith & Nephew plc is quoted on the London Stock Exchange (symbol SN-L).
In the United States, the company's ordinary shares are traded in the form of American Depositary Shares, evidenced by ADRs, and trade on the New York Stock Exchange under the symbol SNN. Each American Depositary Share represents five ordinary shares.
Smith & Nephew is a member of the FTSE 100 and FTSE Eurotop 300 indices as member of the health sector and is also a member of techMARK, the London Stock Exchange's market for innovative technology companies. In addition we are part of the Morgan Stanley Healthcare Index, usually called MSCI, the Dow Jones Sustainability Index and the FTSE4Good ethical share index.
Smith & Nephew is a member of the FTSE 100 and FTSE Eurotop 300 indices as member of the health sector and is also a member of techMARK, the London Stock Exchange's market for innovative technology companies. In addition we are part of the Morgan Stanley Healthcare Index, usually called MSCI, the Dow Jones Sustainability Index and the FTSE4Good ethical share index.
Smith & Nephew's ISIN number is GB0009223206
Smith & Nephew's CUSIP number is 83175M205.
The company's share price is quoted daily in national UK newspapers, as well as on Ceefax and Teletext and at http://www.londonstockexchange.com/ where it is updated at intervals throughout the day. The Financial Times Cityline Service, telephone 0906 0034043, provides an up to the minute share price. A fee is charged for this service.
The company's ADR price is quoted daily in the Wall Street Journal and can be obtained from the official New York Stock Exchange website.
You can also find 15 minute delayed stock price information on our website.
Past performance cannot be relied upon as a guide to future performance.
The company's share price is quoted daily in national UK newspapers, as well as on Ceefax and Teletext and at http://www.londonstockexchange.com/ where it is updated at intervals throughout the day. The Financial Times Cityline Service, telephone 0906 0034043, provides an up to the minute share price. A fee is charged for this service.
The company's ADR price is quoted daily in the Wall Street Journal and can be obtained from the official New York Stock Exchange website.
You can also find 15 minute delayed stock price information on our website.
Past performance cannot be relied upon as a guide to future performance.
Smith & Nephew ordinary shares can be bought or sold through a stockbroker, bank, or generally through a financial institution that provides brokerage services.
Dividend payments on Smith & Nephew's shares are declared by the board of directors and are typically payable in May and November.
The company's dividend history can be found on our website.
Past performance cannot be relied upon as a guide to future performance.
Dividend payments on Smith & Nephew's shares are declared by the board of directors and are typically payable in May and November.
The company's dividend history can be found on our website.
Past performance cannot be relied upon as a guide to future performance.
The company has a dividend re-investment plan that offers shareholders the opportunity to invest their cash dividends in Smith & Nephew shares, which are purchased in the market at competitive dealing costs.
Application forms for re-investing the dividend are available from Equiniti Registrars who administer the plan on behalf of the company.
Equiniti Registrars
The Causeway, Worthing
West Sussex, BN99 6DS
Telephone 0870 600 3996
The company has a dividend re-investment plan that offers shareholders the opportunity to invest their cash dividends in Smith & Nephew shares, which are purchased in the market at competitive dealing costs.
Application forms for re-investing the dividend are available from Equiniti Registrars who administer the plan on behalf of the company.
Equiniti Registrars
The Causeway, Worthing
West Sussex, BN99 6DS
Telephone 0870 600 3996
For information about the ordinary shareholdings, dividends and changes to personal details all shareholders should contact: Equiniti Registrars, The Causeway, Worthing, West Sussex, BN99 6DS. Telephone 0870 600 3996.
All enquiries regarding ADR holder accounts, personal detail changes and payment of dividends should be addressed to Bank of New York, 620 Avenue of the Americas, New York, New York 10011. Telephone 1-800-BNY-ADS (toll free).
For information about the ordinary shareholdings, dividends and changes to personal details all shareholders should contact: Equiniti Registrars, The Causeway, Worthing, West Sussex, BN99 6DS. Telephone 0870 600 3996.
All enquiries regarding ADR holder accounts, personal detail changes and payment of dividends should be addressed to Bank of New York, 620 Avenue of the Americas, New York, New York 10011. Telephone 1-800-BNY-ADS (toll free).
To view information about your shareholdings on the Internet, register at http://www.shareview.com/, the Equiniti enquiry and portfolio management service for shareholders. When you have registered for shareview you will also be able to register your proxy instructions online and elect to receive future shareholder communications via our website.
All enquiries regarding ADR holder accounts and payment of dividends should be addressed to Bank of New York, 620 Avenue of the Americas, New York, New York 10011.
To view information about your shareholdings on the Internet, register at http://www.shareview.com/, the Equiniti enquiry and portfolio management service for shareholders. When you have registered for shareview you will also be able to register your proxy instructions online and elect to receive future shareholder communications via our website.
All enquiries regarding ADR holder accounts and payment of dividends should be addressed to Bank of New York, 620 Avenue of the Americas, New York, New York 10011.
You may request information, such as an investor package, through our website or by contacting our investor relations department:
Julie Allen
Corporate Affairs
Smith & Nephew plc
15 Adam Street
London WC2N 6LA
Tel: +44 (0)20 7401 7646
Fax: +44 (0)20 7960 2350
E-mail: julie.allen@smith-nephew.com
You may request information, such as an investor package, through our website or by contacting our investor relations department:
Julie Allen
Corporate Affairs
Smith & Nephew plc
15 Adam Street
London WC2N 6LA
Tel: +44 (0)20 7401 7646
Fax: +44 (0)20 7960 2350
E-mail: julie.allen@smith-nephew.com
Online versions of our recent Annual Reports and results statements are available in the Investor Information section of our website. You can also request a hard copy of the company's annual report or 20F by emailing julie.allen@smith-nephew.com
Online versions of our recent Annual Reports and results statements are available in the Investor Information section of our website. You can also request a hard copy of the company's annual report or 20F by emailing julie.allen@smith-nephew.com
Julie Allen
Corporate Affairs
Smith & Nephew plc
15 Adam Street
London WC2N 6LA
Tel: +44 (0)20 7401 7646
Fax: +44 (0)20 7960 2350
E-mail: julie.allen@smith-nephew.com
Julie Allen
Corporate Affairs
Smith & Nephew plc
15 Adam Street
London WC2N 6LA
Tel: +44 (0)20 7401 7646
Fax: +44 (0)20 7960 2350
E-mail: julie.allen@smith-nephew.com
Equiniti Registrars
The Causeway
Worthing
West Sussex
BN99 6DS
Tel: 44 (0) 870 600 3996
Bank of New York
620 Avenue of the Americas
New York
New York 10011
Tel: 1-800-BNY-ADS (toll free)
Contact Equiniti Registrars in Worthing,
West Sussex.
Tel: 44 (0) 870 600 3996
Contact Equiniti Registrars, in Worthing,
West Sussex
Tel: 44 (0) 870 600 3996